NeoBar®

ET Tube Holder

Features & Benefits

  • Skin friendly NeoBond® Hydrocolloid tabs
  • Macro and Jumbo sizes available with medical grade acrylic adhesive
  • Designed to reduce extubations, help prevent palate trauma and allow for better oral care
  • Eliminates need for tape near nose or mouth
  • Can be cut for emergency removal
  • Color coded sizes
  • Not made with natural rubber latex or plasticizer DEHP
  • Individually packaged

Order Sample

Clear selection

SKU: N/A.

NeoBar Sell Sheet

NeoBar Directions for Use One Sheet

NeoBar Directions for Use Poster

NeoBar Multi-language Directions for Use



AUDIT OF A NEW NEONATAL ENDOTRACHEAL TUBE FIXATION DEVICE – THE NEOBAR®

Neonatal Intensive Care Unit, United Kingdom

AIMS

To determine the efficacy of a new neonatal endotracheal tube fixation device by evaluating the prevalence of known complications associated with its use during a five month trial period on the neonatal intensive care unit.

METHOD

Nursing and medical staff completed an evaluation sheet following each initial intubation, and on each subsequent day that the neonate remained intubated. The evaluation sheet contained a number of questions aimed at determining the occurrence of known complications associated with the device, as well as space for free text to highlight new complications.

RESULTS

During the five month period 117 neonates were admitted to the neonatal unit. Thirteen neonates required intubation, a total of twenty two intubations in all. Data was obtained on all twenty two intubations. The correct size NeoBarwas used in 21/22 (95.5%) intubations. Difficulty in securing the endotracheal tube to the NeoBardevice was reported in one case (4.5%), with difficulty adhering the device to the neonate’s skin in 4/22 (18.2%) cases. Concerns regarding a lack of adhesiveness of the device to the skin were recorded on day 1 (17.6%), day 2 (36.4%), and day 3 (33.3%) of intubation. Concerns regarding rubbing of the endotracheal tube against the neonate’s lip were recorded on day 1 (5.9%), day 2 (36.4%) and day 3 (33.3%). Concerns that the NeoBar device was becoming detached from the endotracheal tube were recorded on day 1 (23.5%), day 2 (18.2%) and day 3 (33.3%). In no cases did any of these recorded concerns require any action to resolve.

CONCLUSION

The NeoBar is a safe and effective device used for fixing endotracheal tubes on the neonatal intensive care unit. Complications, principally concerning loss of adhesion of the device to the skin or the endotracheal tube, and rubbing of the endotracheal tube against the neonate’s lip were more prevalent the longer the neonate was intubated, but never resulted in the need to change the device or reintubate. As a result of our audit, all endotracheal tubes on our neonatal intensive care unit are now fixed using the NeoBar device.